Ascites medical therapy

Revision as of 16:49, 18 January 2018 by Eiman (talk | contribs)
Jump to navigation Jump to search

Ascites Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ascites from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ascites medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ascites medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ascites medical therapy

CDC on Ascites medical therapy

Ascites medical therapy in the news

Blogs on Ascites medical therapy

Directions to Hospitals Treating Ascites

Risk calculators and risk factors for Ascites medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: M.Umer Tariq [2]

Overview

Ascites Treatment (DO NOT EDIT)

Recommendations for the treatment of Ascites

  1. Patients with ascites who are thought to have an alcohol component to their liver injury should abstain from alcohol consumption.
  2. First-line treatment of patients with cirrhosis and ascites consists of sodium restriction (88 mmol per day [2,000 mg per day]) and diuretics (oral spironolactone with or without oral furosemide).
  3. Fluid restriction is not necessary unless serum sodium is less than 120 to 125 mmol/L.
  4. An initial therapeutic abdominal paracentesis should be performed in patients with tense ascites. Sodium restriction and oral diuretics should then be initiated.
  5. Diuretic-sensitive patients should preferably be treated with sodium restriction and oral diuretics rather than with serial paracenteses.
  6. Liver transplantation should be considered in patients with cirrhosis and ascites.

Recommendations for the treatment of Refractory Ascites

  1. Serial therapeutic paracenteses are a treatment option in patients with refractory ascites.
  2. Post-paracentesis albumin infusion may not be necessary for a single paracentesis of less than 4 to 5 L.
  3. For large-volume paracentesis, an albumin infusion of 6 to 8 g/L of fluid removed can be considered.
  4. Referral for liver transplantation should be expedited in patients with refractory ascites.
  5. Transjugular intrahepatic portasystemic stent-shunt (TIPS) should be considered in appropriately selected patients who meet criteria similar to those of published randomized trials.
  6. Peritoneovenous shunt, performed by a surgeon experienced with this technique, should be considered for patients with refractory ascites who are not candidates for paracenteses, transplant, or TIPS.

Medical Therapy

  • Medical therapy is based on different grades of ascites.[1]
Grade Description Therapy
Grade I Mild fluid accumulation, only detectable with ultrasonography No treatment
Grade II Moderate fluid accumulation, detectable by physical examination Sodium intake restriction and diuretics
Grade III Severe fluid accumulation, detectable by inspection of flanks bulging Large volume paracentesis followed by sodium intake restriction and diuretics
 
 
 
 
 
 
 
 
 
Portal hypertension
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vasodilator release
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Splanchnic arteriolar vasodilation
 
 
 
 
 
 
 
 
 
 
Splancnic hypertension
 
Beta blockers
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypovolemia and Arterial hypotension
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sympathetic nerve activation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Renin-angiotensin-aldosterone system activation
 
Aldosterone antagonists
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vasopressin activation
 
 
 
 
 
 
 
 
 
 
Increased lymph formation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sodium and water retention
 
Loop diuretics
 
 
 
 
 
 
 
 
 
 
 
 
 
Paracentesis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plasma volume expansion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ascites
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Dietary salt and water intake restriction

  • Limitation of daily sodium intake results in negative sodium balance and also redistribution of fluid retention.
  • Daily avoidance of prepared foods along with no added salt diet would lead to suitable sodium restriction (80–120 mMol, corresponded to 4.6–6.9 grams of salt/day).
  • Water restriction is the absolute therapy for fluid accumulation in uncomplicated ascites. However, decreasing water input to <1 L/day is almost impossible in some patients.[3]

Ascites

  • 1 Grade I
    • No treatment is needed.
  • 2 Grade II
    • 2.1 Adult
    • The goal is weight loss of no more than 1.0 kg/day for patients with both ascites and peripheral edema and no more than 0.5 kg/day for patients with ascites alone.[4]
    • 2.2 Pediatric[5]
      • Preferred regimen (1): Spironolactone 2-3 mg/kg PO as a single morning dose (max. dose 2 mg/kg every 5-7 days)
      • Preferred regimen (2): Furosemide up to 1 mg/kg PO daily (max. dose 40 mg)
      • Preferred regimen (3): Albumin 25% up to 1 g/kg IV daily, up to q8h (until plasma level > 2.5 g/dL)

References

  1. "EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis". J. Hepatol. 53 (3): 397–417. 2010. doi:10.1016/j.jhep.2010.05.004. PMID 20633946.
  2. Pedersen JS, Bendtsen F, Møller S (2015). "Management of cirrhotic ascites". Ther Adv Chronic Dis. 6 (3): 124–37. doi:10.1177/2040622315580069. PMC 4416972. PMID 25954497.
  3. Ginès P, Cárdenas A (2008). "The management of ascites and hyponatremia in cirrhosis". Semin. Liver Dis. 28 (1): 43–58. doi:10.1055/s-2008-1040320. PMID 18293276.
  4. Shear L, Ching S, Gabuzda GJ (1970). "Compartmentalization of ascites and edema in patients with hepatic cirrhosis". N. Engl. J. Med. 282 (25): 1391–6. PMID 4910836.
  5. Giefer, Matthew J; Murray, Karen F; Colletti, Richard B (2011). "Pathophysiology, Diagnosis, and Management of Pediatric Ascites". Journal of Pediatric Gastroenterology and Nutrition. 52 (5): 503–513. doi:10.1097/MPG.0b013e318213f9f6. ISSN 0277-2116.

Template:WH Template:WS